TECHNICAL INSIGHTS - Frost & Sullivan: Boom in Smart Pills Will Reach a New Peak by 2018-2020

Description

TECHNICAL INSIGHTS - Frost & Sullivan:TECHNICAL INSIGHTS - Frost & Sullivan: Boom in Smart Pills Will Reach a New Peak by 2018-2020 PR Newswire LONDON, March 4, 2014 -- Technological advances in minimally invasive and remote controlled devices drive the market The increasing need for convenient diagnostic and accurate therapeutic tools is driving innovation in smart pills. While certain smart pill applications, such as imaging and sensing, have been successfully commercialized, others like drug delivery and surgery are yet to be proven clinically. There is also commercialization preference and focus on wireless capsule endoscopes and ingestible sensors for internal signs monitoring. New analysis from Frost & Sullivan (http://www.technicalinsights.frost.com), Innovations in Smart Pills, finds a clear trend towards minimally invasive and remote controlled devices for diagnosis and therapy. Smart pills are widely used for gastrointestinal imaging too, replacing invasive endoscopes. Advancements in enabling technologies, such as wireless communications, remote patient monitoring, and miniaturization, will widen smart pill applications. "The smart pills industry is likely to experience a burst of new products in the next five to seven years, offering tremendous potential for collaboration between the industry and academia," said Technical Insights Research Analyst Bhargav Rajan.

Informations

• Publié par: frost-sullivan
• Publié le: 04 mars 2014
• Nombre de lectures: 6
• Langue: English

Extrait

TECHNICAL INSIGHTS - Frost & Sullivan: Boom in Smart Pills Will Reach a New Peak by 2018-2020

PR Newswire

LONDON, March 4, 2014

-- Technological advances in minimally invasive and remote controlled devices drive the market

The increasing need for convenient diagnostic and accurate therapeutic tools is driving innovation in smart pills. While certain smart pill applications, such as imaging and sensing, have been successfully commercialized, others like drug delivery and surgery are yet to be proven clinically. There is also commercialization preference and focus on wireless capsule endoscopes and ingestible sensors for internal signs monitoring.